2024. Exfoliated dermatitis and hepatitis to first line anti-tubercular therapy with treatment of drug-sensitive tuberculosis with second line anti-tubercular therapy: a roller coaster ride. Chest Disease Reports. 12, 1 (Jun. 2024). DOI:https://doi.org/10.4081/cdr.12.12626.